App - MM&M - Medical Marketing and Media


Business briefs: Bayer, FDA, Ranbaxy

Bayer’s prostate cancer drug clears FDA three months early; a House committee is pressing the regulator for employment transparancy; and Ranbaxy takes a multi-million dollar hit over violations

Business briefs: PwC, Novartis, iDoc24, FDA

PricewaterhouseCoopers says consumers are talking healthcare, but not about the good stuff; Novartis shuffles 120 Texas jobs; 73% of STD app queries came from men last month; FDA is keeping very busy; and OgilvyCommonhealth hires a consumer head

Business briefs: Roche, Vital Art and Science, Gilead, Sanofi

Roche and Isis pair up for Huntingtons, Vital’s prescription vision app gets approved, FDA approval revives maligned morning sickness drug, Gilead sends hep C therapy to regulators and Sanofi’s emerging market exposure grabs attention.

Shire launches ADHD tech challenge

Taking a page from Sanofi, Shire is preparing to launch a developer challenge “to create technology driven solutions that aid individuals with ADHD during the transition from adolescence into adulthood.”

Company news: Novo Nordisk

Novo Nordisk has launched a hemophilia app; and a report says the Chinese OTC market is going gangbusters